Crossmark

Unveiling the differences: infection disorders associated with tumor necrosis factor α inhibitors in pediatric patients—a pharmacovigilance study (2004–2023)

Crossref DOI link: https://doi.org/10.1007/s00431-025-06152-2

Published Online: 2025-05-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Xiaolin

Wang, Luquan

Sun, Yixin

Yang, Changqing

Wang, Xiaoling

Guo, Peng

Mei, Dong
Funding

Funding for this research was provided by:

Beijing Municipal Hospital Scientific Research Cultivation Plan Project (PX2023043)

The Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 82404757)

Beijing Nova Program (20220484219)

National Key R&D Program of China (2023YFC2706100)
License Information

Text and Data Mining valid from 2025-05-03

Version of Record valid from 2025-05-03
More Information

Article History

Received: 27 December 2024

Revised: 15 April 2025

Accepted: 23 April 2025

First Online: 3 May 2025

Declarations

:

: Not applicable

: Not applicable

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below